Mobic Faces A Baker’s Dozen Of Generic Meloxicam Following ANDA Approvals
This article was originally published in The Pink Sheet Daily
Executive Summary
Roxane immediately launched an authorized generic of Boehringer Ingelheim’s osteoarthritis therapy.
You may also be interested in...
Pfizer Says Celebrex Will Weather Generic Mobic
Pfizer maintains that it is "optimistic" about the future of Celebrex (celecoxib) despite the launch of generic Mobic (meloxicam) July 19
Tarceva Pancreatic Cancer Indication Turned Down In The EU
Roche will consider requesting a re-examination of the negative decision by the Committee for Medicinal Products for Human Use.